Literature DB >> 32660938

Osseous sarcoidosis mimicking metastatic breast cancer.

Henry Li1, Laurence Stillwater2, Mark Bryanton2, Christina A Kim2.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32660938      PMCID： PMC7828862          DOI： 10.1503/cmaj.191661

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  8 in total

Review 1.  Sarcoidosis.

Authors:  Anthony O'Regan; Jeffrey S Berman
Journal:  Ann Intern Med       Date:  2012-05-01       Impact factor: 25.391

2.  Sarcoidosis onset after breast cancer; a potential association.

Authors:  Michael D Schweitzer; Oriana Salamo; Gregory Holt; Elio Donna; Mehdi Mirsaeidi
Journal:  Eur J Intern Med       Date:  2017-08-07       Impact factor: 4.487

3.  Can sarcoidosis and metastatic bone lesions be reliably differentiated on routine MRI?

Authors:  Sandra Leigh Moore; Mark J Kransdorf; Mark E Schweitzer; Mark D Murphey; James S Babb
Journal:  AJR Am J Roentgenol       Date:  2012-06       Impact factor: 3.959

4.  Clinical characteristics of patients with bone sarcoidosis.

Authors:  Ying Zhou; Elyse E Lower; Huiping Li; Yolanda Farhey; Robert P Baughman
Journal:  Semin Arthritis Rheum       Date:  2017-02-10       Impact factor: 5.532

5.  Neoplasia in the etiology of sarcoidosis.

Authors:  Jerome M Reich
Journal:  Eur J Intern Med       Date:  2006-03       Impact factor: 4.487

6.  Sarcoidosis as a benign cause of lymphadenopathy in cancer patients.

Authors:  Ben M Hunt; Eric Vallières; Gordon Buduhan; Ralph Aye; Brian Louie
Journal:  Am J Surg       Date:  2009-03-24       Impact factor: 2.565

Review 7.  Imaging Bone Metastases in Breast Cancer: Staging and Response Assessment.

Authors:  Gary J R Cook; Gurdip K Azad; Vicky Goh
Journal:  J Nucl Med       Date:  2016-02       Impact factor: 10.057

Review 8.  Bone Metastases: An Overview.

Authors:  Filipa Macedo; Katia Ladeira; Filipa Pinho; Nadine Saraiva; Nuno Bonito; Luisa Pinto; Francisco Goncalves
Journal:  Oncol Rev       Date:  2017-05-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.